Hilton Capital Management, LLC Catalent, Inc. Transaction History

Hilton Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$72.36 - $113.1 $44,863 - $70,122	620 Added 26.38%	2,970 $215,000
Q2 2022 Aug 08, 2022	BUY	$87.2 - $114.05 $3,749 - $4,904	43 Added 1.86%	2,350 $252,000
Q1 2022 May 06, 2022	SELL	$94.19 - $124.49 $346,336 - $457,749	-3,677 Reduced 61.45%	2,307 $256,000
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $486,530 - $565,875	4,069 Added 212.48%	5,984 $766,000
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $209,060 - $272,600	1,915 New	1,915 $254,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Hilton Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hilton Capital Management, LLC with notifications on news.